OUR LOCATION

322-Washington,America - 23

(+1)123 456 789

Emergency Call- 24/7 support

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Advanced Materials » Advanced Healthcare » AAD-10761018
  • Global Artificial Heart Valve Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: October 2018 | Report Code: AAD-10761018

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Global Artificial heart valve market report

Global artificial heart valve market deals in device implanted in the heart of the patient with the valvular heart disease. This replacement of diseased valves with artificial heart valves reduces the morbidity and mortality associated with cardiac valve disorders. Global artificial heart valve market is expected to grow at a CAGR of 12% during the period from 2017 to 2024.  Key drivers fueling growth in the market are government funding towards researches related to heart valve, rapid growth in geriatric population and rise in prevalence of heart valve diseases. Unhealthy lifestyle and lack of physical activities causes various cardiac diseases and pathological disorders. Increasing demand for minimally-invasive procedures and technological advancement are also leveraging about more effective heart valve devices. However, high cost and risk associated with Transcatheter Aortic Valve Replacement (TAVR) procedures and strict approval process are hindering factor for the market growth.  

Growth in heart valve disorder fueling  growth in global artificial heart valve market

Rising number of heart valve disorder is the key factor driving the market growth.  According to the   Society of Thoracic Surgeons, every year about 5 million people are diagnosed with  heart valve disease in America.  Moreover, every year about 22,000 people in the U.S. die due to heart valve diseases. These heart valve diseases are diagnosed in all ages of people. However, as per British Heart Foundation, one of the key factors for the rise in the heart valve disorder is due to ageing. These valve diseases can be treated with the valve replacement in the patients of all ages. Thus, rise in the heart valve disease patients is expected to rise the demand for artificial heart valve devices. Further, according to the American college of cardiology, in the United States more than  4 million people annually suffer with mitral valve insufficiency and about  1.5 million cause  aortic stenosis   annually. This rise in demand for artificial heart valve is expected to fuel the growth in the market over the forecast period.

 

 

Source: OBRC Analysis

 

The report on global artificial heart valve market is segmented in to type of valve. Type of heart valve includes:

 

  •   Transcatheter Heart Valves  
  •  Tissue Heart Valves  
  • Mechanical Heart Valves

The report scope is widely categorized on the basis of its type of valve which include, mechanical, tissue and transcatheter heart valves.

Geographically, the market report has been segmented in:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World

North America dominates global artificial heart valve market

North America accounted for the largest market share in terms of revenue for the artificial heart valve market in 2016 followed by Europe and Asia Pacific.  North America is expected to dominate the market during the forecast period. Factors such as rapid growth in ageing population, growth in number of product approvals and rising heart disease patients are driving the market growth in North America. Moreover, Asia Pacific is expected to be the fastest growing region in artificial heart valve market during the forecast period. Factors such as increasing disposable incomes and growing prevalence of high occurrence of heart valve diseases, ageing population along with improvement in healthcare infrastructure contributes to the fastest growth rate of Asia Pacific artificial heart valve market during the forecast period. As ageing population have the highest incidences of hypertension and coronary heart disease as per the Journal of the American college of cardiology. Thus, rapid growth in the ageing population in the Asia Pacific is contributing towards the market growth of the artificial heart valve market. For instance, as per the United Nations population Fund organization, in Asia Pacific ageing population is growing at a significant pace. As per the source, by end of 2050 in Asia pacific 1 in 4 people would be over aged over 60 years. In Asia Pacific about 12.4% of the total population was aged above 60 in 2016.

On the basis of segmentation, the market is segmented in to type of valve.  This type of valve segment is further categorized in to mechanical heart valves, biological heart valves, and transcatheter heart valves. Transcatheter heart valve devices segment accounts for maximum share in the market. The largest share of this segment is due to the rising prevalence of heart valve diseases and these transcatheter heart valve are inserted through minimally-invasive procedures. However, the other type of heart valve type need open heart surgery.

 

Major market players of the global artificial heart valve market are:

  • Boston Scientific Corporation (U.S.)
  • Edwards Lifesciences Corporation (U.S.)
  • Liva Nova PLC (U.K.)
  • Medtronic plc (Ireland)
  • St. Jude Medical, Inc. (Abbott Laboratories Company) (U.S.)
  • Others

These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch whereas, approvals is the key strategy adopted by the companies in the market.

For example:  In august 2017, Medtronic Plc announced that its new avalus pericardial surgical valve for the treatment of aortic valve disease which has received approval from the U.S. FDA and CE mark (conformite european). This is expected to increase the market revenue share of the company. Similarly, in February 2018, Edwards Lifesciences Corporation has received CE mark for its CENTERA valve for aortic stenosis patients for open heart surgery. These approval enables the valves use in patients at intermediate risk and higher risk for open heart surgeries.

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in the market.

Key reasons to buy the report:

  • The report includes market estimation, forecast and analysis for the forecast year 2017-2024.
  • Report includes detailed analysis of different segments such as type, application and material type of market during the forecast period.
  • Identify and understand the strength, opportunities, challenges and threat of market during the forecast period.
  • Covers detailed analysis of Porters 5 force model and other strategic models. Also covers revenues, market share analysis, and competitive landscape analysis of major players of the market.
  • Detailed analysis of various regulatory policies which are affecting market during the forecast period.

How are we different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global artificial heart valve market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the market, with giving extensive SCOT analysis of key companies.

Key findings of the market:

  • Growing prevalence of heart valve diseases across the globe contributes to the growth of market during the forecast period.
  •  Asia-Pacific is expected to be the fastest growing region in market during the forecast period.
  •  Tissue heart valves segment is expected to be the fastest growing segment in market during the forecast period.
  • FDA approval is amongst the key strategy adopted by the market players in the market during the forecast period.   

 

 

 

 

 

 

  1. INTRODUCTION
    1. EXECUTIVE SUMMARY
    2. ESTIMATION METHODOLOGY
  2. MARKET OVERVIEW
    1. GLOBAL ARTIFICIAL HEART VALVE MARKET: EVOLUTION & TRANSITION
    2. MARKET DEFINITION & SCOPE
    3. INDUSTRY STRUCTURE
    4. REGULATORY FRAMEWORK
    5. TOTAL MARKET ANALYSIS
      1. TOP 5 FINDINGS
      2. TOP 5 OPPORTUNITY MARKETS
      3. TOP 5 COMPANIES
      4. TOP 3 COMPETITIVE STRATEGIES
    6. ESTIMATION ANALYSIS
    7. STRATEGIC ANALYSIS
      1. INVESTMENT VS. ADOPTION MODEL
      2. 360-DEGREE INDUSTRY ANALYSIS
      3. PORTERS 5 FORCE MODEL
      4. SEE-SAW ANALYSIS
      5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
    8. COMPETITIVE ANALYSIS
      1. KEY STRATEGIES & ANALYSIS
      2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
    9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
      1. INVESTMENT OPPORTUNITIES BY REGIONS
      2. OPPORTUNITIES IN EMERGING APPLICATIONS
      3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
  3. MARKET DETERMINANTS
    1. MARKET DRIVERS
      1.  RISING GERIATRIC POPULATION AND LIFE EXPECTANCY RATE
      2.  FAVOURABLE COMPENSATION AND REGULATORY APPROVALS  
      3.   GROWING GOVERNMENT INVESTMENT FOR HEART VALVE  RESEARCH AND ANALYSIS
      4.  GROWING PREVALENCE OF HEART DISEASES
    2. MARKET RESTRAINTS
      1.      HIGH COST AND RISK ASSOCIATED WITH REPLACEMENT PROCEDURES
      2.      STRINGENT REGULATORY APPROVAL PROCESS
    3. MARKET OPPORTUNITIES
      1.    STRONG PRODUCT PIPELINE
      2.     HUGE GROWTH OPPORTUNITY IN EMERGING ECONOMIES
    4.   MARKET CHALLENGES
      1.  AVALABILITY OF ALTERNATIVE METHODS
  4. MARKET SEGMENTATION
    1. GLOBAL ARTIFICIAL HEART VALVE MARKET BY    TYPE OF VALVE
      1. MARKET DEFINITION AND SCOPE
      2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
      3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
      4.  OPPORTUNITY MATRIX
      5. MARKET SEGMENTATION
        1. GLOBAL     TRANSCATHETER HEART VALVES   MARKET
          1. ADOPTION SCENARIO & MARKET DETERMINANTS
          2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          3. KEY CONCLUSIONS
        2. GLOBAL    TISSUE HEART VALVES   MARKET
          1. ADOPTION SCENARIO & MARKET DETERMINANTS
          2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          3. KEY CONCLUSIONS
        3. GLOBAL    MECHANICAL HEART VALVES MARKET
          1. ADOPTION SCENARIO & MARKET DETERMINANTS
          2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          3. KEY CONCLUSIONS

 

  1. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIES
      1. LIST OF MERGERS AND ACQUISITION
      2. LIST OF JOINT VENTURES
      3. LIST OF PRODUCT LAUNCHES
      4. LIST OF PARTNERSHIPS
  2. GEOGRAPHIC ANALYSIS
    1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    3. OPPORTUNITY MATRIX
    4.  GLOBAL ARTIFICIAL HEART VALVE MARKET BY REGION 2015-2024 ($ MILLION)
      1. NORTH AMERICA
        1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
        2. TOP COUNTRY ANALYSIS
          1. U.S.
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY CONCLUSIONS
          2. CANADA
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY CONCLUSIONS
      2. EUROPE
        1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
        2. TOP COUNTRY ANALYSIS
          1. UK
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY CONCLUSIONS
          2. FRANCE
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
          3. GERMANY
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY CONCLUSIONS
          4. SPAIN
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY CONCLUSIONS
          5. REST OF EUROPE
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY CONCLUSIONS
      3. ASIA PACIFIC
        1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
        2. TOP COUNTRY ANALYSIS
          1. CHINA
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY CONCLUSIONS
          2. INDIA
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY CONCLUSIONS
          3. JAPAN
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY CONCLUSIONS
          4. AUSTRALIA
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY CONCLUSIONS
          5. REST OF ASIA PACIFIC
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY CONCLUSIONS
      4. ROW
        1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
        2. TOP COUNTRY ANALYSIS
          1. LATIN AMERICA
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY CONCLUSIONS
          2. MIDDLE EAST & AFRICA
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY CONCLUSIONS
  3. COMPANY PROFILES
    1.    BOSTON SCIENTIFIC CORPORATION (U.S.)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    2.  BRAILE BIOMEDICA (BRAZIL)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    3.    COLIBRI HEART VALVE, LLC (U.S.)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    4.    CRYOLIFE, INC. (U.S.)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    5.   EDWARDS LIFESCIENCES CORPORATION (U.S.)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    6. HEART LEAFLET TECHNOLOGY (U.S.)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    7.    JENAVALVE TECHNOLOGY, INC.(GERMANY)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    8.    LIVANOVA PLC (U.K.),
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    9.    LEPU MEDICAL TECHNOLOGY CO LTD (CHINA)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    10. LEMAN CARDIOVASCULAR (SWITZERLAND)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    11.    MEDTRONIC PLC (IRELAND)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    12.   MICRO INTERVENTIONAL DEVICES, INC. (U.S.)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    13.  ST. JUDE MEDICAL, INC. (AN ABBOTT LABORATORIES COMPANY) (U.S.)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    14.  SYMETIS SA (SWITZERLAND)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    15.    TTK HEALTHCARE LIMITED (A TTK GROUP COMPANY) (INDIA)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS

LIST OF TABLES

  1. GLOBAL ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  2. GLOBAL TRANSCATHETER HEART VALVES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  3. GLOBAL TISSUE HEART VALVES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  4. GLOBAL   MECHANICAL HEART VALVES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  5.  NORTH AMERICA ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  6. EUROPE ARTIFICIAL HEART VALVE MARKET  2015-2024 ($ MILLION)
  7. ASIA PACIFIC ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  8. REST OF THE WORLD ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  9. NORTH AMERICA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  10. EUROPE ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  11. ASIA PACIFIC ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  12. REST OF THE WORLD ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  13. UNITED STATES (U.S.) ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  14. CANADA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE   2015-2024 ($ MILLION)
  15. UNITED KINGDOM (UK) ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE   2015-2024 ($ MILLION)
  16. FRANCE ARTIFICIAL HEART VALVE MARKET   BY TYPE OF VALVE  2015-2024 ($ MILLION)
  17. GERMANY ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  18. SPAIN ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  19. ROE ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  20. INDIA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  21. CHINA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  22. JAPAN ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  23. AUSTRALIA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  24. ROAPAC ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  25. LATIN AMERICA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)
  26. MENA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE  2015-2024 ($ MILLION)

LIST OF FIGURES

  1. GLOBAL TRANSCATHETER HEART VALVES MARKET   2015-2024 ($ MILLION)
  2. GLOBAL TISSUE HEART VALVES MARKET   2015-2024 ($ MILLION)
  3. GLOBAL    MECHANICAL HEART VALVES MARKET  2015-2024 ($ MILLION)
  4. UNITED STATES (U.S.) ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  5. CANADA ARTIFICIAL HEART VALVE MARKET  2015-2024 ($ MILLION)
  6. UNITED KINGDOM (UK) ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  7. FRANCE ARTIFICIAL HEART VALVE MARKET   2015-2024 ($ MILLION)
  8. GERMANY ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  9. SPAIN ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  10. ROE ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  11. INDIA ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  12. CHINA ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  13. JAPAN ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  14. AUSTRALIA ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  15. ROAPAC ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  16. LATIN AMERICA ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
  17. MENA ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)

 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.